Funded Biotechnology Research Startups in United States
Within this 18-company slice of funded Biotechnology Research startups in the United States, the only disclosed round above $50M is Expedition Medicines’ $…
Within this 18-company slice of funded Biotechnology Research startups in the United States, the only disclosed round above $50M is Expedition Medicines’ $50M (2025-10-22). That $50M figure sits alongside another $50M disclosed round, Avidicure’s $50M (2025-04-24), while most other disclosed amounts cluster below that ceiling, including Living Carbon’s $21M (2023-01-17) and Concerto Biosciences’ $23M (2022-11-02). An outlier on the low end is Walela’s $50K (2022-11-01), which is far below the next-smallest disclosed amounts in the list.
Date-wise, the newest entries are concentrated in 2026: FibroBiologics (2026-06-29, $3M), Foamlab (2026-04-23, $4M), and Intrinsic Foundries (2026-02-17, $1M). City-wise, Boston, Massachusetts appears repeatedly (Intrinsic Foundries 2026-02-17, Nanite 2023-02-15, Living Carbon 2023-01-17, Empatica 2022-11-22, Sensorium Therapeutics 2022-11-08, Concerto Biosciences 2022-11-02), indicating a tight geographic cluster. Stage classification is also uneven: 5 of 18 entries list “Series Unknown,” and one entry is “undisclosed” (Empatica, 2022-11-22).
Most recent rounds
18 shownRelated listings
Frequently asked
What’s the largest disclosed round here, and how does it compare to the rest of the disclosed amounts?
The largest disclosed amount in this list is $50M, shared by Expedition Medicines on 2025-10-22 and Avidicure on 2025-04-24. Beyond those two rounds, the next-highest disclosed amounts are materially lower, including Living Carbon at $21M (2023-01-17) and Concerto Biosciences at $23M (2022-11-02).
Are any time windows over-represented among the most recent rounds shown?
Yes. Three of the newest rounds close in 2026—FibroBiologics ($3M, 2026-06-29), Foamlab ($4M, 2026-04-23), and Intrinsic Foundries ($1M, 2026-02-17). Separately, 2022-11-08 appears as a mini-cluster with Sensorium Therapeutics ($30M) and The Citizen Science Lab ($500K) both dated 2022-11-08.
Which geography shows the strongest clustering in this dataset?
Boston, Massachusetts is the clear concentration point, with multiple entries including Intrinsic Foundries (2026-02-17, $1M), Nanite (2023-02-15, $6M), Living Carbon (2023-01-17, $21M), Empatica (2022-11-22, undisclosed), Sensorium Therapeutics (2022-11-08, $30M), and Concerto Biosciences (2022-11-02, $23M).
How dominant is the “Series Unknown” or “undisclosed” labeling in these rounds?
Out of 18 rows, 5 are labeled “Series Unknown” (e.g., FibroBiologics on 2026-06-29 for $3M; Auxilium Biotechnologies on 2025-10-23 for $4M; Orange Grove Bio on 2024-04-24 for $5M), and 1 is “undisclosed” (Empatica on 2022-11-22). That means 6 of 18 entries do not provide a specific round stage label.
Are there notable low-amount outliers worth reviewing, even if most rounds are larger?
Walela stands out as a low-disclosed outlier at $50K (2022-11-01), far below other small disclosed entries such as Love Lifesciences at $280K (2022-11-23) and Cybele Microbiome at $890K (2022-11-14). This low-end spread contrasts with multiple $4M–$6M rounds like Foamlab ($4M, 2026-04-23) and Nanite ($6M, 2023-02-15).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.